> ## Content Index > Fetch the complete content index at: https://www.whiteroseintelligence.com/llms.txt > Use this file to discover other available public pages before exploring further. # Amanda Cohn - URL: https://www.whiteroseintelligence.com/amanda-cohn/ - Published: 1999-01-02T09:56:00.000Z - Updated: 2024-12-31T22:47:42.000Z - Author: Liam Sturgess - Tags: Profiles, #docs, #individual Dr. **Amanda Cooper Cohn**, MD, is an American pediatrician based in Atlanta, Georgia.[\[1\]](#fn1) She is the director of the Division of Birth Defects and Infant Disorders within the National Center for Birth Defects and Developmental Disabilities (NCBDDD) at the [Centers for Disease Control and Prevention](https://www.whiteroseintelligence.com/Centers-for-Disease-Control-and-Prevention) (CDC).[\[2\]](#fn2) In this role, she acts as a liaison representative on Canada's [National Advisory Committee on Immunization](https://www.whiteroseintelligence.com/National-Advisory-Committee-on-Immunization) (NACI).[\[3\]](#fn3) Cohn is a Commander in the United States Public Health Service.[\[4\]](#fn4) ## Background Cohn is board certified in pediatrics and is a fellow of the American Academy of Pediatrics.[\[5\]](#fn5) She attended Brown University where she received a Bachelor of Arts in English.[\[6\]](#fn6) She obtained her medical degree from Emory University School of Medicine and completed a residency in pediatrics at Boston Children’s Hospital and Boston Medical Center in Massachusetts.[\[1:1\]](#fn1)[\[7\]](#fn7) ### Career Before becoming director of NCBDDD, Cohn previously served as Executive Secretariat of the [Advisory Committee on Immunization Practices](https://www.whiteroseintelligence.com/Advisory-Committee-on-Immunization-Practices) (ACIP) and Chief Medical Officer for the National Center for Immunization and Respiratory Diseases (NCIRD).[\[6:1\]](#fn6) Prior to that role, she served as the Acting Director for the National Center on Birth Defects and Developmental Disabilities and Deputy Director for Immunization Services Division for NCIRD.[\[8\]](#fn8)[\[9\]](#fn9) She is the recipient of the CDC 2009 Iain Hardy Memorial Award for “outstanding contributions to vaccine-preventable diseases.”[\[10\]](#fn10) Cohn has participated on the planning committee for the Forum on Microbial Threats, chaired by EcoHealth Alliance President Peter Daszak.[\[11\]](#fn11)[\[12\]](#fn12) ## Research Cohn has co-authored research on meningococcal vaccines.[\[13\]](#fn13) ### COVID-19 Cohn was a co-author on the study identifying the first SARS-CoV-2 infection in the United States, published in March 2020 in the *New England Journal of Medicine*.[\[14\]](#fn14) ## External links - [Campfire Wiki](https://www.campfire.wiki/doku.php?id=amanda%5Fcohn) - [LinkedIn](https://www.linkedin.com/in/amanda-cohn-95371b107/) --- 1. *Dr. Amanda Cohn Internal Medicine/Pediatrics. Atlanta GA.* WebMD. Retrieved April 21, 2022, from [↩︎](#fnref1) [↩︎](#fnref1:1) 2. National Center on Birth Defects and Developmental Disabilities. (2022, April 15). *Biography - Amanda Cohn, MD.* Centers for Disease Control and Prevention. [↩︎](#fnref2) 3. *National Advisory Committee on Immunization (NACI): Membership and representation.* (2020, December 14). Government of Canada. [↩︎](#fnref3) 4. Cohn, A. (2011, April 6). *Amanda Cohn, MD CDR, US Public Health Service National Center for Immunization and Respiratory Diseases April 6, 2011 Epidemiology of Meningococcal Disease - \[PPTX Powerpoint\].* India Document. [↩︎](#fnref4) 5. Fellows in the News. (2014). *AAP News, 35*(7), 32–32\. [↩︎](#fnref5) 6. *CAPT Amanda Cohn.* U.S. Food and Drug Administration. Retrieved April 21, 2022, from [↩︎](#fnref6) [↩︎](#fnref6:1) 7. Mead, A. (2021, May 12). *Vaccinating Rural America: Q&A with Dr. Amanda Cohn.* The Rural Monitor. [↩︎](#fnref7) 8. *National Center on Birth Defects and Developmental Disabilities (NCBDDD) - Amanda Cohn, MD (CAPT, USPHS).* (2020, February 3). Centers for Disease Control and Prevention. [↩︎](#fnref8) 9. *Capt. Amanda Cohn, MD.* (2021). University of New Mexico. [↩︎](#fnref9) 10. *ACIP Updates on Vaccine Recommendations.* (2017, November 4). Eventscribe. [↩︎](#fnref10) 11. *Planning Committee on the Critical Public Health Value of Vaccines: Tackling Issues of Access and Hesitancy.* (2021). National Academies Press (US). [↩︎](#fnref11) 12. Forum on Microbial Threats. (2021). *The Critical Public Health Value of Vaccines: Tackling Issues of Access and Hesitancy: Proceedings of a Workshop.* (J. Liao, C. Minicucci, & A. Nicholson, Eds.). National Academies Press. [↩︎](#fnref12) 13. Terranella, A., Cohn, A., & Clark, T. (2011). Meningococcal conjugate vaccines: optimizing global impact. *Infection and Drug Resistance, 4*, 161\. [↩︎](#fnref13) 14. Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., Diaz, G., Cohn, A., Fox, L., Patel, A., Gerber, S. I., Kim, L., Tong, S., Lu, X., Lindstrom, S., & Pallansch, M. A. (2020). First Case of 2019 Novel Coronavirus in the United States. *New England Journal of Medicine, 382*(10), 929–936\. [↩︎](#fnref14)